Transforming medicine

Publication of Annual Report and Financial Statements for the Year ended 31 December 2021

Scheme of Arrangement Information Sheet

Proposed Transaction with Eagle Pharmaceuticals, Inc. (Part 1 of 2)

Proposed Transaction with Eagle Pharmaceuticals, Inc (Part 2 of 2)

Acacia Pharma Announces Chief Financial Officer Gary Gemignani is to Leave the Company